Restless legs syndrome and drug-induced akathisia in headache patients. (Q44511356)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Restless legs syndrome and drug-induced akathisia in headache patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

restless legs syndrome

1 reference

inferred from title

drug-induced akathisia

1 reference

William B Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Elcio J Piovesan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Kevin M Biglan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

450-456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

Neuromuscular transmission in migraine: a single-fiber EMG study in clinical subgroups

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

The pharmacologic treatment of neuroleptic-induced akathisia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Intravenous benztropine and propranolol challenges in acute neuroleptic-induced akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Treatment of restless legs syndrome with gabapentin

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Complicating factors in the analysis of acute drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Restless legs with antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Opioid responsiveness in patients with neuroleptic-induced akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Enkephalins and nigrostriatal function

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Clinical susceptibility to migraine with aura is modified by dopamine D 2 receptor (DRD2) Nco I alleles

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Dopamine and migraine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Restless legs syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

A new approach to emergency department therapy of migraine headache with intravenous haloperidol: a case series

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Akathisia with haloperidol and thiothixene

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Influence of rate of administration of raclopride on akathisia and prolactin response

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

The Prevalence of Acute Extrapyramidal Signs and Symptoms in Patients Treated With Clozapine, Risperidone, and Conventional Antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Restless Legs Syndrome among working-aged women

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Iron status and restless legs syndrome in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Propranolol treatment of olanzapine-induced akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Managing antipsychotic-induced acute and chronic akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

The neuropsychiatry of brain iron.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Acute akathisia after oral droperidol and metoclopramide preoperative medication

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Droperidol Treatment of Status Migrainosus and Refractory Migraine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Intravenous benztropine and propranolol challenges in tardive akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Chronic Headaches and Sleep Disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Blepharoclonus, pseudoasterixis, and restless feet

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Ropinirole for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Risk factors for the development of neuroleptic induced akathisia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Treatment of periodic leg movement disorder and restless leg syndrome with talipexole

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Fibromyalgia is common in patients with transformed migraine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Restless legs syndrome and paroxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Extrapyramidal side effects of clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Restless legs syndrome improved by pramipexole: a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Restless legs syndrome: clinicoetiologic correlates

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

A randomized controlled study of pergolide in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018769

7 January 2021

10.1017/S1092852900018769

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12858135%20AND%20SRC:MED&resulttype=core&format=json